A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy Journal Article


Authors: Spurr, L. F.; Martinez, C. A.; Katipally, R. R.; Iyer, S. C.; Pugh, S. A.; Bridgewater, J. A.; Primrose, J. N.; Domingo, E.; Maughan, T. S.; D’Angelica, M. I.; Talamonti, M.; Posner, M. C.; Connell, P. P.; Weichselbaum, R. R.; Pitroda, S. P.
Article Title: A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy
Abstract: Personalized treatment approaches for patients with limited liver metastases from colorectal cancer are critically needed. By leveraging three large, independent cohorts of patients with colorectal liver metastases (n = 336), we found that a proliferative subtype associated with elevated CIN70 scores is linked to immune exclusion, increased metastatic proclivity, and inferior overall survival in colorectal liver metastases; however, high CIN70 scores generate a therapeutic vulnerability to DNA-damaging therapies leading to improved treatment responses. We propose CIN70 as a candidate biomarker to personalize systemic treatment options for patients with metastatic colorectal cancer. These findings are potentially broadly applicable to other human cancers. © 2022, The Author(s).
Keywords: treatment response; human cell; major clinical study; overall survival; exon; fluorouracil; cancer combination chemotherapy; cancer patient; topotecan; cell proliferation; progression free survival; carcinoembryonic antigen; analytic method; cohort analysis; cytotoxicity; cell population; tumor marker; irinotecan; image quality; dna damage response; hepatectomy; eosin; hematoxylin; cancer tissue; gene dosage; oxaliplatin; drug sensitivity; genetic code; aneuploidy; partial hepatectomy; complementary dna; rna degradation; antiproliferative activity; chromosome arm; clinical outcome; cancer prognosis; colorectal liver metastasis; human; article; rna sequencing; ic50; leave one out cross validation; cin70 score
Journal Title: npj Precision Oncology
Volume: 6
ISSN: 2397-768X
Publisher: Springer Nature  
Date Published: 2022-10-14
Start Page: 72
Language: English
DOI: 10.1038/s41698-022-00318-z
PROVIDER: scopus
PMCID: PMC9568565
PUBMED: 36241710
DOI/URL:
Notes: Article -- Export Date: 1 November 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors